U.S. Customs and Border Protection (CBP) has a dangerous new rule beginning Oct. 22 that will threaten the healthcare of millions of Americans. The rule, “Indefinite Suspension of the De Minimis …
Join our family of readers for as little as $10 per month and support local, unbiased journalism.
Already have an account? Log in to continue. Otherwise, follow the link below to join.
Please log in to continue |
U.S. Customs and Border Protection (CBP) has a dangerous new rule beginning Oct. 22 that will threaten the healthcare of millions of Americans. The rule, “Indefinite Suspension of the De Minimis Exemption for Mail Shipments,” will effectively end Americans’ ability to personally import their prescription medicines.
Importing prescription drugs from licensed international pharmacies is the only lifeline for seniors on limited incomes, people with high-deductible health plans, and the uninsured. That’s why CBP and the FDA have allowed it for decades. Due to the much lower cost of medications in Canada and other countries, imported medicine is their only option.
Many imported drugs can be less than half the U.S. price. These necessary medicines prevent blood clots, treat diabetes, and much more. This CBP rule will cut off access to the only affordable prescription drugs for millions, and that will lead to unnecessary harm and preventable deaths.
I ask readers to immediately call or write our Senators and U.S. Representatives and demand they stop CBP from implementing any rule-making that restricts Americans from importing personal-use prescription drugs from licensed pharmacies in Canada or other countries.